| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Memory Disorders | |||||
| Alzheimer's Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Alzheimer Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Delirium, Dementia, Amnestic, Cognitive Disorders | |||||
| Dementia | |||||
| Mental Disorders | |||||
| Nervous System Diseases | |||||
| Neurobehavioral Manifestations | |||||
| Neurodegenerative Diseases | |||||
| Neurologic Manifestations | |||||
| Signs and Symptoms | |||||
| Tauopathies | |||||
| 4 | Interventions listed in this trial | ||||
| Aricept | |||||
| IFN-alpha2A | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Interferon Alfa-2a | |||||
| Interferon-alpha | |||||
| 6 | More general drug interventions related to this trial | ||||
| Angiogenesis Inhibitors | |||||
| Angiogenesis Modulating Agents | |||||
| Anti-Infective Agents | |||||
| Antineoplastic Agents | |||||
| Antiviral Agents | |||||
| Growth Inhibitors | |||||
| Growth Substances | |||||
| Immunologic Factors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Center for Research Resources (NCRR) | |||||
| Pfizer | |||||
|
